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Selenium is an essential dietary element with antioxidant
roles in immune regulation, but there is little understanding of
how this element acts at the molecular level in host defense and
inflammatory disease. Selenium is incorporated into the amino
acid selenocysteine (Sec), which in turn is inserted into selenoproteins in a manner dependent on Sec tRNA[Ser]Sec. To investigate the molecular mechanism that links selenium to T cell
immunity, we generated mice with selenoprotein-less T cells by
cell type-specific ablation of the Sec tRNA[Ser]Sec gene (trsp).
Herein, we show that these mutant mice exhibit decreased pools
of mature T cells and a defect in T cell-dependent antibody
responses. We also demonstrate that selenoprotein deficiency
leads to oxidant hyperproduction in T cells and thereby suppresses T cell proliferation in response to T cell receptor stimulation. These findings offer novel insights into immune function
of selenium and physiological antioxidants.

decoded by UGA (5, 6). Although numerous studies have elucidated various aspects of the incorporation of Sec into protein
(5–7), the complete biosynthesis of this amino acid on its tRNA
in eukaryotes and archaea was only determined recently (8).
One of the principal activities of selenoproteins is related to
scavenging physiological oxidants and thereby protecting
redox-sensitive biological processes (9). Reactive oxygen species (ROS) and other forms of oxidants have long been considered deleterious byproducts of mitochondrial and endosomal
metabolic activities. However, their regulatory roles in cellular
signaling have begun to be unveiled in the study of growth factorstimulated cells (10, 11). The effects of selenium on immunity and
other aspects of human health may be achieved through selenoprotein action in ROS regulation. In this paper, we describe our
study focused on the function of selenoproteins in T cell development and activation and propose a model wherein their antioxidant activity links selenium to T cell immunity.

Numerous health benefits have been attributed to selenium,
including roles in preventing cancer, metabolic, and inflammatory
disorders, and in inhibiting viral expression and pathogenesis (1).
Overall, little is known about the molecular action of this element
in effecting these many health benefits. This is certainly true in the
case of the role of selenium in immune function (2– 4).
Many of the physiological roles of selenium are thought to be
derived from selenium-containing proteins (selenoproteins)
(1). Selenium makes its way into protein as selenocysteine
(Sec),3 the 21st amino acid in the genetic code, which is

EXPERIMENTAL PROCEDURES
Generation of ⌬trspT Mice—A C57BL/6 mouse line carrying
floxed trsp (trspfl/fl, designated as the control) was described
previously (12). A transgenic C57BL/6 line carrying the LckCre
transgene (13) was from The Jackson Laboratory. These lines
were mated to obtain ⌬trspT mice. The maintenance and care
of all mice were in accordance with the National Institutes of
Health institutional guidelines.
75
S Labeling and Analysis of Selenoproteins—Mice were
injected with 50 Ci of 75Se/g and sacrificed after 24 h. T cells
were isolated (see below) and lysed; the resulting protein
extractions were electrophoresed on gels; and the gels were
stained with Coomassie Blue R-250, vacuum-dried, and
exposed to a PhosphorImager as described (12, 14).
Isolation and Analysis of T Cells—CD3⫹ T cells were purified
by negative selection using the Mouse T Cell Negative Isolation
Kit (Dynal). Cell purity and marker expression (CD3, CD4,
CD8, and IL-2R␣) were determined by flow cytometry using
fluorescence-conjugated antibodies and a FACScan (BD
Biosciences).
T Cell Activation—1 ⫻ 106 T cells were placed into 96-well
plates in triplicate and stimulated with 10 g/ml each antimouse CD3⑀ (145-2C11) and anti-CD28 (37.51) antibodies (BD
Biosciences). Culture supernatants were assayed for IL-2 production using the Searchlight Assay (Pierce). To measure cell proliferation, cells were pulsed with 1 Ci/well of [3H]thymidine at vari-
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FIGURE 1. Generation and characterization of ⌬trspT mice. A, the genotypes
of tissues and T cells obtained from control and ⌬trspT mice are shown. Th, thymus; Sp, spleen; Ln, lymph nodes; TC, T cells; Tl, tail; Ht, heart; Lu, lung; Kd, kidney,
Lv, liver; Br, brain; flox, floxed. B, the levels of tRNA[Ser]Sec and tRNASer in thymic T
cells isolated from control and ⌬trspT mice as determined by Northern blotting
are shown. C, the protein levels of glutathione peroxidase 1 (GPX1) and ␤-tubulin
in T cells obtained from tissues as indicated of control and ⌬trspT mice as determined by immunoblotting are shown. D, 75Se-labeled selenoproteins are visualized by autoradiography after SDS electrophoresis. The identities of the major
labeled selenoproteins (14) are designated to the right. GPX4, glutathione peroxidase 4; TR, thioredoxin reductase; CBB, Coomassie Brilliant Blue.

ous time points after T cell receptor (TCR) stimulation, and the
amount of [3H]thymidine incorporation was measured in a scintillation counter. Cells were preincubated with NAC (Sigma) in
some experiments as described under “Results”.
Immunoblotting and ROS Measurement—ROS were measured by flow cytometry using the oxidation-sensitive dye
DCFDA by modifying the previous procedure (15–17). The
level of ERK activation was determined by immunoblotting
with antibodies specific to total and phosphorylated ERK proteins (Cell Signaling Technology).
Antibody Response in Vivo—Mice were immunized with 100
g of NP-OVA (Biosearch Technologies). NP-specific immunoglobulin levels were determined in all serum samples (diluted
1:100) by standard enzyme-linked immunosorbent assay on
NP-bovine serum albumin-coated plates.

RESULTS
Generation of Mice Lacking Selenoproteins in T Cells—Gene
expression profiling shows that specific sets of selenoprotein
mRNAs are expressed in T cells from various lymphoid organs
(supplemental Fig. S1). To generate mice whose T cells are
devoid of selenoproteins, we targeted the removal of the floxed
Sec tRNA[Ser]Sec gene (trsp) in mice (12) by Cre recombinase
expressed under the control of the Lck promoter (13). The T
cell-restricted expression of LckCre was confirmed previously
(18). The lymph nodes, splenocytes, and thymocytes, as well as
purified T cells of trspfl/fl-LckCre mice (hereafter designated
⌬trspT), exhibited trsp deletion, whereas other non-lymphoid tissues did not (Fig. 1A). Northern blot analysis of Sec RNA[Ser]Sec in
purified T cells showed that trsp ablation resulted in the loss of
this tRNA (Fig. 1B), whereas Western blot analysis of glutathione peroxidase 1, which is among the selenoproteins highly
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expressed in T cells (see below), showed that this selenoprotein
was virtually absent in T cells of ⌬trspT mice (Fig. 1C). To further examine selenoprotein expression in T cells, control (genotype trspfl/fl) and ⌬trspT mice were labeled with 75Se, the T
cells were isolated from thymus, and labeled selenoproteins
were examined by gel electrophoresis. The level of 75Se-labeled
selenoproteins was substantially reduced in T cells from the
⌬trspT mouse as compared with the corresponding control
cells (Fig. 1D). The pattern of labeling is similar to that observed
in human T cells wherein the various selenoproteins were identified (14).
Analysis of Lymphoid Organs and T Cell Differentiation in
⌬trspT Mice—We examined thymus, spleen, and lymph nodes
of ⌬trspT mice and found that they exhibited moderate to
severe atrophy compared with their control counterparts; the
mass and cellularity of the thymus, spleen, and lymph nodes
were decreased to varying extents ranging between 50 and 80%
of those of control organs. We further investigated the T cell
population of ⌬trspT lymphoid organs by flow cytometry. The
level of CD4/CD8 double positive cells was slightly higher, and
those of single positive CD4⫹ and CD8⫹ cells were significantly
less in the ⌬trspT thymocytes relative to control thymocytes
(Fig. 2A). CD4⫺ and CD8⫺ thymocytes were unaffected by selenoprotein loss. We next examined splenic T cells in control
and ⌬trspT mice. The CD3⫹ population in ⌬trspT splenocytes
was about 50% as compared with that in control splenocytes
(Fig. 2B), suggesting that trsp deficiency brings about a reduction in the mature and functional pool of T cells in lymphoid
tissues. The relative fraction of CD4⫹ cells among the CD3⫹
population in ⌬trspT spleen was similar to that in control spleen
(Fig. 2C). However, it should be noted that the absolute numbers of splenic CD3⫹ and CD4⫹ cells in ⌬trspT mice are lower
than in control mice at ratios similar to those of thymic CD4⫹
cells (Fig. 2A). The CD8⫹ T cell subpopulation was more substantially reduced in the same ⌬trspT CD3⫹ splenocytes. The
partial loss of functional T cells, particularly CD8⫹ T cells, that
results from T cell-specific selenoprotein deficiency may affect
the responsiveness of the immune system to external as well as
self antigens.
It is unclear at present how T cell-specific trsp deficiency
leads to defects in the development and/or maintenance of
mature T cell populations. Nonetheless, the decrease in the
CD8⫹ T cell population in ⌬trspT mice may result in inadequate cytotoxic T cell immunity. Of note, several studies
showed that selenium deficiency in diet, a condition that also
causes loss or reduction of selenoprotein function, exacerbates
viral pathogenesis and impairs antiviral immunity (19, 20).
Activation of Selenoprotein-deficient T Cells by T Cell Receptor Signaling—Antigenic stimulation of the TCR-CD3 complex
induces proliferation and functional activation of T cells. These
responses are greatly potentiated by concomitant activation of
costimulatory receptors such as CD28. To test whether TCRtriggered responses require selenoprotein function, T cells
were purified from control and ⌬trspT lymph nodes and were
cultured in the presence of anti-CD3 and anti-CD28 antibodies,
a condition that mimics TCR and costimulatory receptor activation. We first investigated the ability of the T cells to proliferate in response to TCR activation by measuring the rate of
VOLUME 283 • NUMBER 29 • JULY 18, 2008
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FIGURE 2. Analysis of lymphoid organs and T cell differentiation in ⌬trsp
mice. T cells isolated from lymphoid organs of control and ⌬trspT mice were
analyzed by flow cytometry. The results shown are representative of six different experiments (n ⫽ 6). A, CD4 and CD8 expression in thymocytes were
analyzed. The subpopulations corresponding to CD4/CD8 DP, as well as CD4⫹
and CD8⫹ SP cells, are indicated by circles along with their percent levels.
B and C, total splenocytes were gated into CD3⫹ cells and further analyzed for
CD4 and CD8 expression. CD3⫹ cells CD4/CD8 DP (B) and CD4⫹ and CD8⫹ SP
cells (C) are indicated as in A. SSC, side scatter.
T

[3H]thymidine incorporation. Control T cells that were incubated with anti-CD3 antibody alone or together with antiCD28 antibody showed greatly enhanced levels of proliferation
compared with unstimulated cells. The TCR-induced proliferation of T cells from ⌬trspT lymph nodes was dramatically
lower under the same conditions (Fig. 3A). We also examined
splenic T cells from control and ⌬trspT mice and obtained similar results (data not shown; also see Fig. 4B). Therefore, selenoprotein expression in T cells appears to be crucial for their
ability to proliferate in response to TCR stimulation.
Activated T cells produce IL-2, which exerts an autocrine,
feed-forward effect on T cell proliferation. In parallel, TCR activation also leads to higher expression of the IL-2 receptor (ILJULY 18, 2008 • VOLUME 283 • NUMBER 29

FIGURE 3. Activation of selenoprotein-deficient T cells by TCR stimulation. A, the level of proliferation of purified lymph node T cells is shown as
the amounts of [3H]thymidine incorporation after 60 h of incubation in the
absence or presence of anti-CD3/CD28 or anti-CD3 alone. Results are the
averages of triplicate readings from six control and ⌬trspT mice, respectively.
B and C, the levels of IL-2 production (B) and cell surface expression of IL-2R␣
(C) in CD3/CD28-stimulated T cells are shown. D, ERK activation in lymph node
T cells stimulated with anti-CD3 and anti-CD28 was analyzed at the time intervals indicated. Both phosphorylated (pERK) and total (ERK) proteins are
shown. E, serum levels of major immunoglobulins at the indicated time points
were determined by enzyme-linked immunosorbent assay in control and
⌬trspT mice following immunization with NP-OVA. Circles represent immunoglobulin levels of each animal. Error bars represent the mean values.

2R) complex on T cells. We analyzed IL-2 production and IL-2R
expression in T cells from control and ⌬trspT mice following
CD3/CD28 stimulation. Both groups of T cells produced similar amounts of IL-2 in response to TCR activation (Fig. 3B). The
IL-2R induction, on the other hand, occurred to a much lesser
extent in T cells lacking trsp (Fig. 3C). Therefore, we expect that
selenoproteins in activated T cells function to enhance their
IL-2 responsiveness. TCR is coupled to multiple intracellular
signaling modules. It was shown that the mitogen-activated
protein kinase ERK links TCR activation to T cell proliferation
(21). We therefore analyzed ERK activation in T cells in
JOURNAL OF BIOLOGICAL CHEMISTRY
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response to CD3/CD28 stimulation. T cells from control but
not ⌬trspT mice showed rapid appearance of the active (phosphorylated) forms of ERK following treatment with anti-CD3
and anti-CD28 antibodies (Fig. 3D).
We found that elimination of tRNA[Ser]Sec and resultant selenoprotein deficiency in T cells cause defects in the development of functionally mature T cells and their TCR-dependent
activation. It is highly likely that these multiple anomalies collectively contribute to impairing T cell-mediated immune
responses. To verify this reasoning, we immunized control and
⌬trspT mice with NP-OVA, an antigen that elicits antibody production in a T cell-dependent fashion. At different time points
after immunization, the serum levels of antigen-specific immunoglobulins were determined by enzyme-linked immunosorbent assay. Regardless of the immunoglobulin classes, the
serum levels of antigen-specific antibodies were poorly raised
in ⌬trspT mice (Fig. 3E). This in vivo finding reveals a link
between selenoprotein loss and defective T cell immunity in
mice.
A Role for Reactive Oxygen Species in the Impaired Proliferation of Selenoprotein-deficient T Cells—Many selenoproteins
serve as antioxidant enzymes and possess Sec residues at their
catalytic center. Such selenoenzymes eliminate ROS within and
outside the cell and thereby protect ROS-sensitive molecular
events against oxidative inactivation. It was shown that TCR
activation leads to rapid production of ROS (15) and also that
an NADPH oxidase is involved in this process (16). Most
importantly, ROS production in TCR-stimulated cells was
found to inhibit ERK signaling in T cells (17). These pieces of
information prompted us to test whether selenoprotein-deficient T cells produce higher ROS than control cells and, if so,
how this relates to T cell defects in ⌬trspT mice.
We first determined the level of basal and TCR-stimulated
ROS generation by labeling cells with cell-permeant, oxidationsensitive DCFDA dye. Intriguingly, DCFDA oxidation due to
ROS generation occurred at higher rates in T cells from ⌬trspT
mice than in control cells even without TCR stimulation (Fig.
4A). TCR stimulation resulted in increased ROS production in
control T cells up to a level comparable with that of basal ROS
production in trsp-deficient T cells (Fig. 4A). T cells from
⌬trspT mice did not show further increases in ROS production
upon TCR stimulation. These data suggest that selenoproteins
are indeed important for suppressing ROS production in T
cells. Therefore, loss of selenoprotein function may render T
cells defective in TCR-induced and ROS-sensitive responses.
The action of endogenously produced ROS can be blocked by
pharmacological antioxidants such as NAC. We tested whether
NAC can reverse the effect of selenoprotein deficiency in T
cells. Incubation of trsp-deficient T cells with NAC restored the
ability of the cell to proliferate in response to TCR stimulation
(Fig. 4B). NAC also increases the proliferation response of control T cells. However, NAC alone did not induce T cell proliferation (Fig. 4B). Taken together, these findings indicate that
selenoproteins are critically required for limiting ROS production in T cells and thus preventing ROS-mediated suppression
of T cell activation.

20184 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 4. ROS production in TCR-stimulated T cells and its role in the
impaired proliferation of selenoprotein-deficient T cells. A, ROS production was analyzed by flow cytometry using DCFDA as described under “Experimental Procedures.” T cells, either unstimulated or stimulated with anti-CD3
antibody for 12 min, were used. B, T cells were either unstimulated (None) or
stimulated as indicated in the presence of various concentrations of NAC. T
cell proliferation was analyzed as in Fig. 3A. Values represent the average and
S.E. of three separate experiments.

DISCUSSION
Chronically elevated ROS levels may perturb a variety of cellular functions mediated by ROS-sensitive signaling pathways.
We found that selenoproteins play a crucial role in T cell proliferation in response to TCR stimulation. The finding that the
antioxidant NAC can compensate for selenoprotein deficiency
in T cells and reverse their defect of TCR-induced proliferation
strongly argues for a function of selenoproteins as antioxidants.
Exact molecular targets in T cells that selenoproteins protect
against ROS effects remain to be identified. ERK signaling is one
of the likely candidates, as it is essential for T cell proliferation
(21), and its activation is inhibited by endogenous ROS produced upon TCR stimulation (17). However, we do not rule out
possible contributions of other molecules in this selenoproteinROS regulatory network.
It was previously shown that dietary selenium deprivation in
mice led to reductions in T cell marker expression in muscle
(22) and T cell proliferation (23). Intriguingly, replenishment
of selenium reversed those changes in both studies. Furthermore, selenium supplementation has been found to be an
effective treatment in delaying the progression of viral replication and boosting host defense in immunocompromised
patients (19, 20). The data presented in this report provide
first-hand molecular evidence that selenoproteins indeed
have essential and non-redundant functions in T cell immunity. Our ⌬trspT mouse model can open up new horizons of
research in immune regulation by dietary trace elements and
antioxidants.
REFERENCES
1. Hatfield, D. L., Berry, M. L., and Gladyshev, V. N. (2006) Selenium: Its
Molecular Biology and Role in Human Health, 2nd Ed., pp. 1– 419,
Springer, New York, NY
2. Hoffmann, P. R. (2007) Arch. Immunol. Ther. Exp. 55, 289 –297
3. Hoffmann, P. R., Jourdan-Le Saux C., Hoffman, F. W., Chang, P. S., Bollt,
O., He, Q., Tam, E. K., and Berry, M. J. (2007) J. Immunol. 179, 3258 –3267
4. Kiremidjian-Schumacher, L., Roy, M., Wishe, H. I., Cohen, M. W., and
Stotzky, G. (1992) Biol. Trace Elem. Res. 33, 23–35

VOLUME 283 • NUMBER 29 • JULY 18, 2008

Selenoproteins in T Cell Immunity
5. Driscoll, D. M., and Copleand, P. R. (2003) Annu. Rev. Nutr. 23, 17– 40
6. Hatfield, D. L., Carlson, B. A., Xu, X. M., Mix, H., and Gladyshev, V. N.
(2006) Prog. Nucleic Acid Res. Mol. Biol. 81, 97–142
7. Copeland, P. R. (2005) Genome Biol. 6, 221
8. Xu, X. M., Carlson, B. A., Mix, H., Zhang, Y., Saira, K., Glass, R. S.,
Berry, M. J., Gladyshev, V. N., and Hatfield, D. L. (2006) PLoS Biol.
5, 96 –105
9. Papp, L. V., Lu, J., Holmgren, A., and Khanna, K. K. (2007) Antioxid. Redox
Signal. 9, 775– 806
10. Rhee, S. G. (2006) Science 312, 1882–1883
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SUPPLEMENTAL DATA
SUPPLEMENTAL EXPERIMENTAL PROCEDURE
Quantitative Real-Time PCR- Total RNA was isolated from purified T cells of lymph node, spleen and
thymus using Trizol (Invitrogen) according to manufacturer’s instructions. Testes and liver total RNAs
were used as controls. 2µg of RNA was used for first strand cDNA synthesis using an iScript cDNA
Synthesis Kit as per manufacturer’s instructions (Bio-Rad). To measure the levels of various
selenoprotein gene expression this cDNA was used as a template for amplification by real-time PCR
using a MyiQTM Real-Time PCR Detection System (Bio-Rad). Twenty ng of cDNA was utilized for the
PCR reaction, using iQTM SYBR Green Supermix (Bio-Rad) and 500 nM of each primer, under the
following conditions: Step 1: Initial denaturation at 95°C for 4 min. Step 2: 40 cycles each at 95°C for 10
sec, 56°C for 20 Sec and 72°C for 30 sec. Step 3: 59 cycles at 66°C for 10 sec and final hold up at 10°C.
Selenoproteins analyzed (Supplemental Table 1) are shown in Supplemental Fig. 1 (S1) as relative
mRNA level to Gusb (internal control).
Supplemental Table 1 Selenoprotein gene primers for assessing real-time PCR.
Gene
Forward Sequence
Reverse Sequence
Dio1
5’-AGGAACCATAGGCATTGGAA-3’
5’-CCAGAGAGCCAGATTCCTGT-3’
Dio2
5’- GACTCACCAGCCCATGTAAC-3’
5’- CGTGTGACTACATCCAACCA-3’
Dio3
5’- CAGAGTGGCACCATCATGTA-3’
5’- TCAGTCACTTGTCCCTTGGT-3’
Gpx1
5’-CAGGAGAATGGCAAGAATGA-3’
5’-GAAGGTAAAGAGCGGGTGAG-3’
Gpx2
5’- ATCAAACGGCTCCTCAAAGT-3’
5’- GGGACGATATTCAGGGAATG-3’
Gpx3
5’-CCCTTAGTGCATTCAGGCTT-3’
5’-GACCTTTACTGGGCAGATGG-3’
Gpx4
5’-GCAGGAGCCAGGAAGTAATC-3’
5’-GGCTGGACTTTCATCCATTT-3’
SelH
5’-CTACCTGTGCAAGTGAACCC-3’
5’-TGAGGCTCAGGAAATTTGAG-3’
SelI
5’-CCGTGTTTGCTCTTCACTTT-3’
5’-GCTGACATGTGATATTGGCA-3’
SelK
5’-TGGTGGATGAGGAAGGTAAA-3’
5’-ACAGAGCAATCCTTGTTTGG-3’
SelM
5’-GATTGGAACCGTCTTCGAG-3’
5’-GTGCTTCATCACCAGGTTGT-3’
SelN
5’- CCCTAGGTAGCCTTCTGTGC-3’
5’- ACAGGCTGAAGGGTAGCAGT-3’
SelO
5’-ATCGACTATGGACCCTTTGG-3’
5’-TTTCTGCAGATTCCACTTGC-3’
SelP
5’-ATCTTGGCAGCAGTAAGCCT-3’
5’-TCACTTGCTGTGGTGTCTCA-3’
SelR
5’-TCCAGTCACTCGAAGTACGC-3’
5’-CTTGCCACAGGACACCTTTA-3’
SelS
5’-CTTTGCGAGGAGGTGGTTAT-3’
5’-CCTTGCTAATGTCAGAGCGA-3’
SelT
5’-TGGTCTAAGCTGGAATCTGG-3’
5’-TTTCGGTGCTGATAGGTAGG-3’
SelV
5’-AATTCCCAAACCTTCTGGAG-3’
5’-GACTCATCCACAAAGCCATC-3’
SelW
5’-TAGAGGCAGGGTCCTGAAAG-3’
5’-AATCCATCTCTGGCCTGACT-3’
Sep15
5’-TGGAACACAGACAGTGTGGA-3’
5’-TGACCAATGTAAGCATGCAA-3’
Sps2
5’-GATAGTGCCGTGGTAGGAGA-3’
5’-CTCTGGAAACCACCATCTTG-3’
TR1
5’-CTACAGACCATTGCCTTGCT-3’
5’-ACCTCCTACCCACAAGATCC-3’
TGR
5’-CTGGAATATGGCTGTTGTGG-3’
5’-AGGTGTTGTTGTCTCTGCCA-3’
TR3
5’-TCACTGGAATTGGACTGGAT-3’
5’-ACACAGCCTTTCAGGAACTG-3’
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Supplemental Fig. S1. Profiling of selenoprotein gene expression in T cells. Selenoprotein gene
expression in T cells purified from lymph node, spleen, thymus, liver and testes was verified by real-time
PCR and is shown as relative mRNA level to GUSB (internal control).
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